JM5-31112-21734
4 vaccinations
1 coded response
35 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 480 / MI
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-22
Registered in v-safe
-
2021-02-22
Dose 1 — Pfizer-BioNTech
-
2021-02-22
Health check-in — day 0, dose 1Feeling: Good · Site: Swelling · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Fatigue or tirednessAdult check-in
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Fatigue or tirednessAdult check-in
-
2021-02-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-03-01
Health check-in — day 7, dose 1Feeling: Good · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-03-08
-
2021-03-15
Dose 2 — Pfizer-BioNTech
-
2021-03-15
Health check-in — day 0, dose 2Feeling: Fair · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-31
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-06-14
- 2021-09-13
-
2021-10-08
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-15
-
2022-10-09
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: COVID-19 positive. Sore throat for a day, runny nose, cough, fatigue. Sx for about a week. No fevers, headache, or difficulty breathing.MedDRA releases: 2024-11 · check-in free text available
-
2023-04-20
Dose 4 — Pfizer-BioNTech
- 2023-04-23
- 2023-04-24
- 2023-04-25
- 2023-04-26
- 2023-04-27
- 2023-05-04
- 2023-05-11
- 2023-05-18
- 2023-05-25
- 2023-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-22 | Pfizer-BioNTech | |
| 2 | 2021-03-15 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | Flu |
| 4 | 2023-04-20 | Pfizer-BioNTech | No |
Free text
Release 12 — 12 months, dose 3
Symptoms: COVID-19 positive. Sore throat for a day, runny nose, cough, fatigue. Sx for about a week. No fevers, headache, or difficulty breathing.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release